首页> 美国卫生研究院文献>other >In vitro and In vivo Assessment of CdTe and CdHgTe Toxicity and Clearance
【2h】

In vitro and In vivo Assessment of CdTe and CdHgTe Toxicity and Clearance

机译:CdTe和CdHgTe毒性和清除率的体外和体内评估

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Semiconductor QDs are being developed as fluorescent tags for biomedical applications such as imaging, targeting, therapeutic carriers, drug delivery, nanomedicine, and in vitro and in vivo biological labeling. However, potential toxicity and clearance of semiconductor QDs in biological systems are of concerned. We have tested toxicity and clearance in vitro and in vivo (subcutaneous)of CdTe and CdHgTe semiconductor QDs in human breast cancer MCF7 and MBA-MD-231 cells and prostate cancer PC3 cells over a period of 40 days. Our results show that both CdTe and CdHgTe QDs are cytotoxic to human breast and prostate cancer cells. CdHgTe ODs were cleared rapidly from the site of injection, while CdTe were still detectable 18 days after injection, but were cleared by 30 days.
机译:半导体QD正在开发为荧光标签,用于生物医学应用,例如成像,靶向,治疗载体,药物递送,纳米医学以及体外和体内生物标记。但是,在生物系统中半导体QD的潜在毒性和清除率值得关注。我们已经在40天的时间内测试了CdTe和CdHgTe半导体QD在人乳腺癌MCF7和MBA-MD-231细胞以及前列腺癌PC3细胞中的体外和体内(皮下)毒性和清除率。我们的结果表明,CdTe和CdHgTe量子点都对人乳腺癌和前列腺癌细胞具有细胞毒性。从注射部位可以快速清除CdHgTe OD,而注射后18天仍可检测到CdTe,但到30天后即可清除。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号